Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1427690

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1427690

Alcoholic Hepatitis Treatment Global Market Report 2024

Published: Pre-Order
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

Alcoholic hepatitis treatment involves interventions aimed at promoting abstinence from alcohol and addressing the symptoms of liver damage. The therapeutic approach to alcoholic hepatitis focuses on the cessation of alcohol consumption and the administration of medications to alleviate liver-related symptoms.

The primary modalities of treatment for alcoholic hepatitis include pharmaceutical interventions and stem cell therapy. Pharmaceutical treatment entails the use of medications, excluding food, to prevent, detect, treat, or alleviate the symptoms of diseases or abnormal conditions. Drug classes such as corticosteroids, hemorheologic agents, monoclonal antibodies, anabolic steroids, and others are administered through oral and injectable routes. These treatments are typically provided by healthcare facilities, clinics, and private treatment centers.

The alcoholic hepatitis treatment market research report is one of a series of new reports from The Business Research Company that provides alcoholic hepatitis treatment market statistics, including alcoholic hepatitis treatment industry global market size, regional shares, competitors with an alcoholic hepatitis treatment market share, detailed alcoholic hepatitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the alcoholic hepatitis treatment industry. This alcoholic hepatitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alcoholic hepatitis treatment market size has grown strongly in recent years. It will grow from $2.95 billion in 2023 to $3.18 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth observed in the historic period for alcoholic hepatitis treatment can be attributed to factors such as a high prevalence of alcohol abuse, increased awareness and diagnostics, government initiatives addressing alcoholism, a rise in healthcare expenditure, and the impact of public health campaigns.

The alcoholic hepatitis treatment market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period for alcoholic hepatitis treatment is expected to be driven by factors such as the emergence of novel therapies and a promising drug pipeline, the adoption of precision medicine approaches, an enhanced understanding of disease pathogenesis, a rising focus on liver health, and the implementation of public health policies addressing alcohol abuse. Major trends in the forecast period include the adoption of personalized medicine approaches, trends in liver transplantation, the integration of telemedicine and remote monitoring, collaborative research initiatives, and the development of innovative drug solutions.

The escalating prevalence of liver diseases stemming from alcohol consumption is poised to be a significant driver fueling the expansion of the market for alcoholic hepatitis treatment. Alcoholic liver disease manifests as a result of impaired liver function. The liver, responsible for numerous physiological functions such as blood detoxification and bile production aiding digestion, experiences damage due to alcohol consumption. Treatment for alcoholic hepatitis targets liver inflammation in affected patients, often necessitating therapy in a hospital setting for those with severe manifestations of the condition. For instance, data from the National Library of Medicine in December 2021 predicted that an increase in alcohol use of one year during the COVID-19 pandemic could lead to 8,000 additional alcohol-related liver disease-related deaths, 18,700 cases of liver failure, and 1,000 instances of liver cancer by 2040. Hence, the heightened prevalence of alcohol-induced liver diseases acts as a significant impetus propelling the alcoholic hepatitis treatment market's growth.

The burgeoning emphasis on personalized medicine is anticipated to drive the expansion of the alcoholic hepatitis treatment market in the foreseeable future. Personalized medicine denotes an innovative medical approach that considers individual variations in patients' genetic makeup, environments, and lifestyles. This approach enables tailored treatment strategies, encompassing the customization of therapies, identification of susceptibility factors, optimized medication selection, individualized risk evaluation, and mitigation of adverse effects. It fosters patient engagement and compliance by aligning treatment plans with individual needs. For example, reports published by STAT in October 2022 indicated the availability of over 75,000 genetic testing products and 300 personalized medicines. This surging focus on personalized medicine stands as a significant catalyst propelling the growth of the alcoholic hepatitis treatment market.

Product innovation stands as a prominent and increasingly adopted trend within the alcoholic hepatitis treatment market. Companies engaged in this sector are placing significant emphasis on pioneering new products to maintain their competitive edge. An illustrative example is the July 2022 release by Roche Holding AG of the Elecsys HCV Duo, a groundbreaking dual antibody and antigen diagnostic test for hepatitis C virus (HCV). This innovative test enables independent and simultaneous detection of HCV antigen and antibody status using a single human plasma or serum sample. It aids in identifying patients in recovery or exhibiting chronic infection symptoms that might lead to conditions such as liver cancer or early-stage infections. The early manifestation of HCV's core antigen during infection, utilized as an indicator of ongoing viral replication, enables physicians to diagnose active HCV at an earlier stage compared to using solely antibody assays, enhancing diagnostic capabilities.

Prominent entities in the alcoholic hepatitis treatment market are channeling their efforts towards product development, specifically focusing on immunoassays, as a strategic driver for revenue generation. Immunoassays represent a type of biochemical testing method leveraging antibodies' specific binding to antigens to detect and quantify the presence or concentration of a target molecule (analyte) in a sample. For instance, in November 2023, F. Hoffmann-La Roche Ltd. unveiled Elecsys HBeAg quant, an immunoassay designed to measure hepatitis B e antigen (HBeAg) levels in human serum and plasma in both qualitative and quantitative formats. It serves as a predictive tool for chronic active hepatitis and an early indicator of acute hepatitis B infection. This test aids in diagnosing and monitoring individuals with hepatitis B virus infection when complemented with supplementary laboratory findings and clinical data. The Elecsys HBeAg quant, compatible with Roche's Cobas e analyzers, is intended for use with samples from patients with known positive results as well as those with an undetermined HBeAg status.

In October 2022, the France-based biotechnology company Genfit completed the acquisition of Versantis AG for an undisclosed amount. This strategic move enhances GENFIT's leadership position in acute-on-chronic liver failure (ACLF) and significantly broadens its pipeline. The acquisition brings valuable assets to GENFIT's portfolio, including VS-01-ACLF, a Phase 2-ready program based on first-in-class scavenging liposomes technology, VS-01-UCD, a pediatric program targeting urea cycle disorder (UCD), and VS-02-HE, an early-stage program focusing on hepatic encephalopathy (HE). Versantis AG, based in Switzerland, is a biotech company specializing in the development of therapeutics for hepatitis and alcohol-related liver diseases.

Major companies operating in the alcoholic hepatitis treatment market report are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Sanofi PLC, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Torrent Pharmaceuticals Ltd., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KGaA, Viatris Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Cadila Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Mylan Inc., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, Alkermes PLC, Intercept Pharmaceuticals Inc., Apotex Inc., Durect Corp.

North America was the largest region in the alcoholic hepatitis treatment market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the alcoholic hepatitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alcoholic hepatitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alcoholic hepatitis treatment market consists of revenues earned by entities by providing infection surveillance, ulcer prophylaxis, and liver transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The alcoholic hepatitis treatment market also includes sales of anti-inflammatory medication such as steroids, pentoxifylline, and glucocorticoids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alcoholic Hepatitis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alcoholic hepatitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alcoholic hepatitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alcoholic hepatitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Treatment: Drug Treatment; Stem Cell Therapy
  • 2) By Drug Class: Corticosteroids; Hemorheologic Agents; Monoclonal Antibodies; Anabolic Steroids; Other Drug Classes
  • 3) By Route of Administration: Oral; Injectable
  • 4) By Application: Hospital; Clinic; Private Treatment Center
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r13534

Table of Contents

1. Executive Summary

2. Alcoholic Hepatitis Treatment Market Characteristics

3. Alcoholic Hepatitis Treatment Market Trends And Strategies

4. Alcoholic Hepatitis Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Alcoholic Hepatitis Treatment Market Size and Growth

  • 5.1. Global Alcoholic Hepatitis Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Alcoholic Hepatitis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Alcoholic Hepatitis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Alcoholic Hepatitis Treatment Market Segmentation

  • 6.1. Global Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Treatment
  • Stem Cell Therapy
  • 6.2. Global Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Corticosteroids
  • Hemorheologic Agents
  • Monoclonal Antibodies
  • Anabolic Steroids
  • Other Drug Classes
  • 6.3. Global Alcoholic Hepatitis Treatment Market, Segmentation By Route of Administration:, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Injectable
  • 6.4. Global Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Clinic
  • Private Treatment Center

7. Alcoholic Hepatitis Treatment Market Regional And Country Analysis

  • 7.1. Global Alcoholic Hepatitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Alcoholic Hepatitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Alcoholic Hepatitis Treatment Market

  • 8.1. Asia-Pacific Alcoholic Hepatitis Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Alcoholic Hepatitis Treatment Market

  • 9.1. China Alcoholic Hepatitis Treatment Market Overview
  • 9.2. China Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Alcoholic Hepatitis Treatment Market

  • 10.1. India Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Alcoholic Hepatitis Treatment Market

  • 11.1. Japan Alcoholic Hepatitis Treatment Market Overview
  • 11.2. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Alcoholic Hepatitis Treatment Market

  • 12.1. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Alcoholic Hepatitis Treatment Market

  • 13.1. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Alcoholic Hepatitis Treatment Market

  • 14.1. South Korea Alcoholic Hepatitis Treatment Market Overview
  • 14.2. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Alcoholic Hepatitis Treatment Market

  • 15.1. Western Europe Alcoholic Hepatitis Treatment Market Overview
  • 15.2. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Alcoholic Hepatitis Treatment Market

  • 16.1. UK Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Alcoholic Hepatitis Treatment Market

  • 17.1. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Alcoholic Hepatitis Treatment Market

  • 18.1. France Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Alcoholic Hepatitis Treatment Market

  • 19.1. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Alcoholic Hepatitis Treatment Market

  • 20.13. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Alcoholic Hepatitis Treatment Market

  • 21.1. Eastern Europe Alcoholic Hepatitis Treatment Market Overview
  • 21.2. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Alcoholic Hepatitis Treatment Market

  • 22.1. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Alcoholic Hepatitis Treatment Market

  • 23.1. North America Alcoholic Hepatitis Treatment Market Overview
  • 23.2. North America Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Alcoholic Hepatitis Treatment Market

  • 24.1. USA Alcoholic Hepatitis Treatment Market Overview
  • 24.2. USA Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Alcoholic Hepatitis Treatment Market

  • 25.1. Canada Alcoholic Hepatitis Treatment Market Overview
  • 25.2. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Alcoholic Hepatitis Treatment Market

  • 26.1. South America Alcoholic Hepatitis Treatment Market Overview
  • 26.2. South America Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Alcoholic Hepatitis Treatment Market

  • 27.1. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Alcoholic Hepatitis Treatment Market

  • 28.1. Middle East Alcoholic Hepatitis Treatment Market Overview
  • 28.2. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Alcoholic Hepatitis Treatment Market

  • 29.1. Africa Alcoholic Hepatitis Treatment Market Overview
  • 29.2. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Alcoholic Hepatitis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Alcoholic Hepatitis Treatment Market Competitive Landscape
  • 30.2. Alcoholic Hepatitis Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AbbVie Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Alcoholic Hepatitis Treatment Market Other Major And Innovative Companies

  • 31.1. Sanofi PLC
  • 31.2. Bristol-Myers Squibb Company
  • 31.3. GlaxoSmithKline Plc
  • 31.4. Torrent Pharmaceuticals Ltd.
  • 31.5. Takeda Pharmaceutical Company Limited
  • 31.6. Gilead Sciences Inc.
  • 31.7. Merck KGaA
  • 31.8. Viatris Inc.
  • 31.9. Teva Pharmaceutical Industries Ltd.
  • 31.10. AstraZeneca Plc
  • 31.11. Cadila Pharmaceuticals
  • 31.12. Sun Pharmaceutical Industries Ltd.
  • 31.13. Mylan Inc.
  • 31.14. Dr. Reddy's Laboratories Ltd.
  • 31.15. Cipla Ltd.

32. Global Alcoholic Hepatitis Treatment Market Competitive Benchmarking

33. Global Alcoholic Hepatitis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Alcoholic Hepatitis Treatment Market

35. Alcoholic Hepatitis Treatment Market Future Outlook and Potential Analysis

  • 35.1 Alcoholic Hepatitis Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Alcoholic Hepatitis Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Alcoholic Hepatitis Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!